Uni-Bio Science Group Limited announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was HKD 156.984 million compared to HKD 67.433 million a year ago. Operating income was HKD 3.163 million compared to operating loss of HKD 10.782 million a year ago. Net income was HKD 1.917 million compared to net loss of HKD 11.458 million a year ago. Basic earnings per share from continuing operations was HKD 0.0003 compared to basic loss per share from continuing operations of HKD 0.0018 a year ago.